CD4 and infectious mononucleosis: Our data suggest that the gH/gL-ferritin vaccine may effectively engage CD4+ T cell subsets, which is particularly important for preventing infectious mononucleosis, where overly polarized Th1 responses can exacerbate immunopathology [32].